ALK and mycosis fungoides: For instance, miR-155, which was first identified as abnormally expressed in CTCLs, can be used as an oncogenic driver to promote tumor growth in both MF and anaplastic lymphoma kinase (ALK)-negative anaplastic large-cell lymphoma (ALCL) (18, 51).